Kyung Jin Oh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kyung Jin Oh has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Hee Joung Choi
Department of Pediatrics, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea
6 shared publications - Jae Hee Seol
Department of Pediatrics, Yonsei University Wonju College of Medicine, Wonju, Korea
6 shared publications - Jae Yoon Na
Department of Pediatrics, Hanyang University College of Medicine, Seoul, Republic of Korea
6 shared publications - Min-Jung Cho
Department of Pediatrics, Gyeongsang National University Changwon Hospital, Changwon, Korea
6 shared publications - Soo-Jin Kim
Department of Pediatrics, Sejong General Hospital, Bucheon, Korea
6 shared publications - Jinyoung Song
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
5 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by Korean Society of Kawasaki Disease in Kawasaki Disease
- Vol. 4 (1)
Kawasaki Disease Shock Syndrome Associated with Influenza Infection Followed by Systemic Juvenile Idiopathic Arthritis: A Diagnostic Dilemma
Kawasaki disease (KD) is an acute systemic vasculitis of childhood that requires careful differentiation from infectious and immune-mediated diseases. Kawasaki disease shock syndrome (KDSS), a severe form of KD characterized by hemodynamic instability, may further complicate the diagnostic process. We report the case of a 5-year-old boy who was initially diagnosed with complete KD accompanied by influenza infection and KDSS. The patient responded to intravenous immunoglobulin and methylprednisolone, achieved clinical stabilization, and was discharged. However, during outpatient follow-up, he presented to the emergency department with recurrent fever and severe polyarticular pain involving the neck, fingers, knees, and hips, resulting in marked limitation of mobility. Subsequent evaluation raised suspicion for systemic juvenile idiopathic arthritis, and the patient was transferred to a tertiary care center with access to pediatric rheumatology expertise for inpatient management. The clinical course, characterized by viral infection at the time of KD diagnosis followed by the development of an immune-mediated disease, suggests a possible shared inflammatory mechanism between KD and systemic inflammatory diseases. This case highlights the diagnostic challenges in distinguishing KD from other inflammatory diseases and underscores the need for additional evaluation criteria with higher specificity beyond current symptom-based diagnostic approaches. Further studies are warranted to clarify the relationship between KD and immune-mediated diseases.
- 30 June 2026
- Published by Korean Society of Kawasaki Disease in Kawasaki Disease
- Vol. 4 (1)
Open AccessKawasaki Disease Shock Syndrome Associated with Influenza Infection Followed by Systemic Juvenile Idiopathic Arthritis: A Diagnostic Dilemma
Kawasaki disease (KD) is an acute systemic vasculitis of childhood that requires careful differentiation from infectious and immune-mediated diseases. Kawasaki disease shock syndrome (KDSS), a severe form of KD characterized by hemodynamic instability, may further complicate the diagnostic process. We report the case of a 5-year-old boy who was initially diagnosed with complete KD accompanied by influenza infection and KDSS. The patient responded to intravenous immunoglobulin and methylprednisolone, achieved clinical stabilization, and was discharged. However, during outpatient follow-up, he presented to the emergency department with recurrent fever and severe polyarticular pain involving the neck, fingers, knees, and hips, resulting in marked limitation of mobility. Subsequent evaluation raised suspicion for systemic juvenile idiopathic arthritis, and the patient was transferred to a tertiary care center with access to pediatric rheumatology expertise for inpatient management. The clinical course, characterized by viral infection at the time of KD diagnosis followed by the development of an immune-mediated disease, suggests a possible shared inflammatory mechanism between KD and systemic inflammatory diseases. This case highlights the diagnostic challenges in distinguishing KD from other inflammatory diseases and underscores the need for additional evaluation criteria with higher specificity beyond current symptom-based diagnostic approaches. Further studies are warranted to clarify the relationship between KD and immune-mediated diseases.
- Open Access
- 1 January 2026
- Published by XMLink in Korean Circulation Journal
- Vol. 56 (11) , 947
2025 Clinical Practice Guidelines for the Management of Fontan Patients in Korea: A Consensus Statement With Graded Recommendations by the Committee for Clinical Practice Guidelines on Fontan Patients
With the growing number of Fontan patients surviving into adulthood in Korea, there is a critical need for evidence-based, Korea-specific guidelines for their long-term management. The 2025 Clinical Practice Guidelines for the Management of Fontan Patients in Korea represent the first national consensus statement developed by the Committee for Clinical Practice Guidelines on Fontan Patients. The recommendations were formulated through systematic review, expert consultation, and integration of international guidelines with Korean cohort data. These guidelines provide graded recommendations and tailored follow
- 1 January 2026
- Published by XMLink in Korean Circulation Journal
- Vol. 56 (11) , 947
Open Access2025 Clinical Practice Guidelines for the Management of Fontan Patients in Korea: A Consensus Statement With Graded Recommendations by the Committee for Clinical Practice Guidelines on Fontan Patients
With the growing number of Fontan patients surviving into adulthood in Korea, there is a critical need for evidence-based, Korea-specific guidelines for their long-term management. The 2025 Clinical Practice Guidelines for the Management of Fontan Patients in Korea represent the first national consensus statement developed by the Committee for Clinical Practice Guidelines on Fontan Patients. The recommendations were formulated through systematic review, expert consultation, and integration of international guidelines with Korean cohort data. These guidelines provide graded recommendations and tailored follow
- 10 October 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (5) , 2225-2240
Optimal Strategy for Thromboprophylaxis in Fontan Circulation: A Systematic Review and Meta-analysis with a Focus on Ethnic Differences
Fontan circulation alters cardiovascular hemodynamics to maintain circulation using a single ventricle, which may consequently increase the risk of thromboembolism. This highlights the need for effective thromboprophylaxis strategies. This study assessed optimal thromboprophylaxis regimens for patients with Fontan circulation through a comprehensive meta-analysis of literature focused on personalized, ethnicity-based approaches. PubMed, Embase, and Cochrane Library databases were searched to identify studies reporting the thromboembolic and bleeding outcomes of patients with Fontan circulation. Thirty reports-four randomized controlled trials and 26 cohort studies-were analyzed. Aspirin (risk ratio [RR], 0.46; 95% confidence interval [CI], 0.2-1.08; p = 0.07), warfarin (RR, 0.40; 95% CI, 0.24-0.65; p < 0.001), and direct oral anticoagulants (DOACs) (RR, 0.22; 95% CI, 0.01-7.57; p = 0.4) were compared with no antithrombotic therapy, and only warfarin use resulted in a statistically significant reduction in thromboembolic risk, whereas the effects of aspirin and DOACs were not statistically significant. In the East Asian subgroup, aspirin significantly decreased thromboembolic risk, compared with no intervention (RR, 0.31; 95% CI, 0.16-0.58; p < 0.001), and was significantly more effective than warfarin (RR, 0.57; 95% CI, 0.37-0.88; p = 0.01). Bleeding risk showed no significant between-group differences. Compared with no intervention, thromboprophylaxis in patients with Fontan circulation reduces thromboembolic risk. Although our findings should be carefully interpreted because of the limited data, they indicate that aspirin may be more effective than warfarin in East Asian patients, underscoring the need for further research into ethnicity-tailored thromboprophylaxis strategies.
- 10 October 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (5) , 2225-2240
Optimal Strategy for Thromboprophylaxis in Fontan Circulation: A Systematic Review and Meta-analysis with a Focus on Ethnic Differences
Fontan circulation alters cardiovascular hemodynamics to maintain circulation using a single ventricle, which may consequently increase the risk of thromboembolism. This highlights the need for effective thromboprophylaxis strategies. This study assessed optimal thromboprophylaxis regimens for patients with Fontan circulation through a comprehensive meta-analysis of literature focused on personalized, ethnicity-based approaches. PubMed, Embase, and Cochrane Library databases were searched to identify studies reporting the thromboembolic and bleeding outcomes of patients with Fontan circulation. Thirty reports-four randomized controlled trials and 26 cohort studies-were analyzed. Aspirin (risk ratio [RR], 0.46; 95% confidence interval [CI], 0.2-1.08; p = 0.07), warfarin (RR, 0.40; 95% CI, 0.24-0.65; p < 0.001), and direct oral anticoagulants (DOACs) (RR, 0.22; 95% CI, 0.01-7.57; p = 0.4) were compared with no antithrombotic therapy, and only warfarin use resulted in a statistically significant reduction in thromboembolic risk, whereas the effects of aspirin and DOACs were not statistically significant. In the East Asian subgroup, aspirin significantly decreased thromboembolic risk, compared with no intervention (RR, 0.31; 95% CI, 0.16-0.58; p < 0.001), and was significantly more effective than warfarin (RR, 0.57; 95% CI, 0.37-0.88; p = 0.01). Bleeding risk showed no significant between-group differences. Compared with no intervention, thromboprophylaxis in patients with Fontan circulation reduces thromboembolic risk. Although our findings should be carefully interpreted because of the limited data, they indicate that aspirin may be more effective than warfarin in East Asian patients, underscoring the need for further research into ethnicity-tailored thromboprophylaxis strategies.
- Open Access
- 26 August 2025
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 9 (9)
Reply: Unifying FALD assessment—A call to arms
- 26 August 2025
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 9 (9)
Open AccessReply: Unifying FALD assessment—A call to arms
- Open Access
- 30 June 2025
- Published by Korean Society of Kawasaki Disease in Kawasaki Disease
- Vol. 3 (1)
Outcomes of Conservative Treatment for Patients with Right Coronary Artery Total Occlusion after Kawasaki Disease
Kawasaki disease (KD) is an acute vasculitis that primarily affects children and can lead to severe coronary artery complications, including total occlusion. This study evaluates the long-term outcomes of conservative management in patients with right coronary artery (RCA) total occlusion following KD. A retrospective review of 78 patients who underwent cardiac computed tomography (CT) between 2000 and 2022 identified seven cases of RCA total occlusion. The median duration from KD diagnosis to RCA occlusion was 2.3 years (range: 0.5–5.7 years). Among seven patients, four patients remained asymptomatic and three experienced mild chest pain. Follow-up assessments, including electrocardiogram, echocardiography, treadmill tests, and myocardial perfusion single-proton emission computed tomography (SPECT), revealed no significant ischemic findings. All patients maintained functional status within New York Heart Association class I over a median follow-up of 7.2 years (range: 1.0–13.5 years). Treatment primarily consisted of triple antithrombotic therapy, including aspirin, clopidogrel, and warfarin, with transient use of low-molecular-weight heparin in select cases. Our findings suggest that conservative management with medical therapy and regular follow-up may be a viable approach for patients with RCA occlusion who exhibit no ischemic symptoms. The development of collateral circulation may play a critical role in preventing myocardial ischemia. However, further studies with larger cohorts and advanced imaging techniques are needed to refine management strategies and assess long-term outcomes.
- 30 June 2025
- Published by Korean Society of Kawasaki Disease in Kawasaki Disease
- Vol. 3 (1)
Open AccessOutcomes of Conservative Treatment for Patients with Right Coronary Artery Total Occlusion after Kawasaki Disease
Kawasaki disease (KD) is an acute vasculitis that primarily affects children and can lead to severe coronary artery complications, including total occlusion. This study evaluates the long-term outcomes of conservative management in patients with right coronary artery (RCA) total occlusion following KD. A retrospective review of 78 patients who underwent cardiac computed tomography (CT) between 2000 and 2022 identified seven cases of RCA total occlusion. The median duration from KD diagnosis to RCA occlusion was 2.3 years (range: 0.5–5.7 years). Among seven patients, four patients remained asymptomatic and three experienced mild chest pain. Follow-up assessments, including electrocardiogram, echocardiography, treadmill tests, and myocardial perfusion single-proton emission computed tomography (SPECT), revealed no significant ischemic findings. All patients maintained functional status within New York Heart Association class I over a median follow-up of 7.2 years (range: 1.0–13.5 years). Treatment primarily consisted of triple antithrombotic therapy, including aspirin, clopidogrel, and warfarin, with transient use of low-molecular-weight heparin in select cases. Our findings suggest that conservative management with medical therapy and regular follow-up may be a viable approach for patients with RCA occlusion who exhibit no ischemic symptoms. The development of collateral circulation may play a critical role in preventing myocardial ischemia. However, further studies with larger cohorts and advanced imaging techniques are needed to refine management strategies and assess long-term outcomes.
- Open Access
- 1 January 2025
- Published by XMLink in Korean Circulation Journal
- Vol. 55 (9) , 813-825
Effects of Exercise Training in Patients With Fontan Circulation: A Systematic Review and Meta-Analysis
Choi HJ, et al. Korean Circ J. 2025 Apr;55:e63. https://doi.org/10.4070/kcj.2024.0381
- 1 January 2025
- Published by XMLink in Korean Circulation Journal
- Vol. 55 (9) , 813-825
Open AccessEffects of Exercise Training in Patients With Fontan Circulation: A Systematic Review and Meta-Analysis
Choi HJ, et al. Korean Circ J. 2025 Apr;55:e63. https://doi.org/10.4070/kcj.2024.0381
- Open Access
- 1 January 2025
- Published by XMLink in Korean Circulation Journal
- Vol. 55 (8) , 721-732
Pulmonary Vasodilator Therapy in Patients With Fontan Circulation: A Meta-Analysis
Cho MJ, et al. Korean Circ J. 2025 Apr;55:e68. https://doi.org/10.4070/kcj.2024.0378
- 1 January 2025
- Published by XMLink in Korean Circulation Journal
- Vol. 55 (8) , 721-732
Open AccessPulmonary Vasodilator Therapy in Patients With Fontan Circulation: A Meta-Analysis
Cho MJ, et al. Korean Circ J. 2025 Apr;55:e68. https://doi.org/10.4070/kcj.2024.0378
- Open Access
- 15 November 2024
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 8 (12)
Clinical predictors and noninvasive imaging in Fontan-associated liver disease: A systematic review and meta-analysis
Background: Despite the development of several imaging modalities for diagnosing Fontan-associated liver disease (FALD), there is no optimal protocol for the follow-up of FALD. We conducted a systematic review and meta-analysis to identify factors related to liver fibrosis using biopsy reports and to identify alternative noninvasive modalities that could better reflect liver histological changes in FALD. Methods: A systematic review and meta-analysis were conducted following the PRISMA guidelines Table S2. We searched Embase, PubMed, and Cochrane databases for studies on FALD, focusing on those assessing clinical factors associated with liver fibrosis severity through liver biopsy and noninvasive imaging techniques. Results: A total of 42 studies were identified, of which 12 conducted meta-analyses and subgroup analyses of the severity of liver fibrosis using liver biopsies. Liver biopsy results showed a weak positive correlation between Fontan duration and fibrosis severity (R = 0.36). Subgroup analyses revealed significant differences in hemodynamic parameters, such as Fontan pressure, between patients with mild and severe fibrosis. Platelet count, aspartate aminotransferase to platelet ratio index, and fibrosis-4 index were significantly associated with fibrosis severity, with severe fibrosis showing lower platelet counts and higher aspartate aminotransferase to platelet ratio index and fibrosis-4 index levels. Noninvasive imaging modalities, particularly magnetic resonance elastography and shear wave elastography, demonstrated strong correlations with biopsy-confirmed fibrosis severity. Conclusions: This study identifies key clinical factors, and noninvasive modalities accurately reflect liver fibrosis severity in patients with FALD. Clinical factors such as platelet count, aspartate aminotransferase to platelet ratio index, and fibrosis-4 index may aid in identifying patients at risk for severe fibrosis. In addition, magnetic resonance elastography and shear wave elastography are promising tools for noninvasive assessment in our study. Further research is needed to refine these diagnostic approaches and improve patient management.
- 15 November 2024
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 8 (12)
Open AccessClinical predictors and noninvasive imaging in Fontan-associated liver disease: A systematic review and meta-analysis
Background: Despite the development of several imaging modalities for diagnosing Fontan-associated liver disease (FALD), there is no optimal protocol for the follow-up of FALD. We conducted a systematic review and meta-analysis to identify factors related to liver fibrosis using biopsy reports and to identify alternative noninvasive modalities that could better reflect liver histological changes in FALD. Methods: A systematic review and meta-analysis were conducted following the PRISMA guidelines Table S2. We searched Embase, PubMed, and Cochrane databases for studies on FALD, focusing on those assessing clinical factors associated with liver fibrosis severity through liver biopsy and noninvasive imaging techniques. Results: A total of 42 studies were identified, of which 12 conducted meta-analyses and subgroup analyses of the severity of liver fibrosis using liver biopsies. Liver biopsy results showed a weak positive correlation between Fontan duration and fibrosis severity (R = 0.36). Subgroup analyses revealed significant differences in hemodynamic parameters, such as Fontan pressure, between patients with mild and severe fibrosis. Platelet count, aspartate aminotransferase to platelet ratio index, and fibrosis-4 index were significantly associated with fibrosis severity, with severe fibrosis showing lower platelet counts and higher aspartate aminotransferase to platelet ratio index and fibrosis-4 index levels. Noninvasive imaging modalities, particularly magnetic resonance elastography and shear wave elastography, demonstrated strong correlations with biopsy-confirmed fibrosis severity. Conclusions: This study identifies key clinical factors, and noninvasive modalities accurately reflect liver fibrosis severity in patients with FALD. Clinical factors such as platelet count, aspartate aminotransferase to platelet ratio index, and fibrosis-4 index may aid in identifying patients at risk for severe fibrosis. In addition, magnetic resonance elastography and shear wave elastography are promising tools for noninvasive assessment in our study. Further research is needed to refine these diagnostic approaches and improve patient management.
- Open Access
- 14 February 2023
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 42 (5) , 423-428
Distinct Clinical and Laboratory Features of COVID-19 in Children During the Pre-Delta, Delta and Omicron Wave
Background: The SARS-CoV-2 variants of concern exhibit distinct features in terms of transmissibility and virulence. This study compared the clinical characteristics of COVID-19 in children during pre-Delta, Delta and Omicron waves. Methods: Medical records of 1163 children <19 years of age with COVID-19 admitted to a designated hospital in Seoul, South Korea, were analyzed. Clinical and laboratory findings during the pre-Delta (March 1, 2020, to June 30, 2021; 330 children), Delta (July 1, 2021, to December 31, 2021; 527 children) and Omicron (January 1, 2022, to May 10, 2022; 306 children) waves were compared. Results: Children during the Delta wave were older and had a higher proportion of fever ≥5 days and pneumonia than children during the pre-Delta and Omicron waves. The Omicron wave was characterized by younger age and a higher proportion of fever ≥39.0 °C, febrile seizure and croup. More children <2 years of age and adolescents aged 10 to <19 years experienced neutropenia and lymphopenia, respectively, during the Delta wave. Children aged 2 to <10 years had a higher incidence of leukopenia and lymphopenia during the Omicron wave. Conclusions: Distinct features of COVID-19 were observed in children during the Delta and Omicron surges. Continuous scrutiny of the manifestations of variants of concern is needed for appropriate public health response and management.
- 14 February 2023
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 42 (5) , 423-428
Open AccessDistinct Clinical and Laboratory Features of COVID-19 in Children During the Pre-Delta, Delta and Omicron Wave
Background: The SARS-CoV-2 variants of concern exhibit distinct features in terms of transmissibility and virulence. This study compared the clinical characteristics of COVID-19 in children during pre-Delta, Delta and Omicron waves. Methods: Medical records of 1163 children <19 years of age with COVID-19 admitted to a designated hospital in Seoul, South Korea, were analyzed. Clinical and laboratory findings during the pre-Delta (March 1, 2020, to June 30, 2021; 330 children), Delta (July 1, 2021, to December 31, 2021; 527 children) and Omicron (January 1, 2022, to May 10, 2022; 306 children) waves were compared. Results: Children during the Delta wave were older and had a higher proportion of fever ≥5 days and pneumonia than children during the pre-Delta and Omicron waves. The Omicron wave was characterized by younger age and a higher proportion of fever ≥39.0 °C, febrile seizure and croup. More children <2 years of age and adolescents aged 10 to <19 years experienced neutropenia and lymphopenia, respectively, during the Delta wave. Children aged 2 to <10 years had a higher incidence of leukopenia and lymphopenia during the Omicron wave. Conclusions: Distinct features of COVID-19 were observed in children during the Delta and Omicron surges. Continuous scrutiny of the manifestations of variants of concern is needed for appropriate public health response and management.
- Open Access
- 1 January 2023
- Published by XMLink in Pediatric Infection & Vaccine
- Vol. 30 (2) , 84-90
Clinical Presentation and Prognosis of SARS-CoV-2 Infection in Infants Aged ≤90 Days: Insights for Management During Outbreaks
Moon HJ, et al. Pediatr Infect Vaccine. 2023 Aug;30(2):84-90. https://doi.org/10.14776/piv.2023.30.e13
- 1 January 2023
- Published by XMLink in Pediatric Infection & Vaccine
- Vol. 30 (2) , 84-90
Open AccessClinical Presentation and Prognosis of SARS-CoV-2 Infection in Infants Aged ≤90 Days: Insights for Management During Outbreaks
Moon HJ, et al. Pediatr Infect Vaccine. 2023 Aug;30(2):84-90. https://doi.org/10.14776/piv.2023.30.e13